{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:56:48Z","timestamp":1791356208133,"version":"4.3.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T00:00:00Z","timestamp":1427068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1038\/nm.3831","type":"journal-article","created":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T15:00:52Z","timestamp":1427122852000},"page":"327-334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":167,"title":["Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection"],"prefix":"10.1038","volume":"21","author":[{"given":"Jonathan H","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis J","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Chen","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M","family":"Staron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A","family":"Parish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia X","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M","family":"Kaech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,23]]},"reference":[{"key":"BFnm3831_CR1","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.coi.2007.06.004","volume":"19","author":"H Shin","year":"2007","unstructured":"Shin, H. & Wherry, E.J. CD8 T cell dysfunction during chronic viral infection. Curr. Opin. Immunol. 19, 408\u2013415 (2007).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnm3831_CR2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cell.2009.06.036","volume":"138","author":"HW Virgin","year":"2009","unstructured":"Virgin, H.W., Wherry, E.J. & Ahmed, R. Redefining chronic viral infection. Cell 138, 30\u201350 (2009).","journal-title":"Cell"},{"key":"BFnm3831_CR3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry, E.J. T cell exhaustion. Nat. Immunol. 12, 492\u2013499 (2011).","journal-title":"Nat. Immunol."},{"key":"BFnm3831_CR4","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry, E.J. et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27, 670\u2013684 (2007).","journal-title":"Immunity"},{"key":"BFnm3831_CR5","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1084\/jem.191.9.1499","volume":"191","author":"F Lechner","year":"2000","unstructured":"Lechner, F. et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191, 1499\u20131512 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnm3831_CR6","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.immuni.2014.10.013","volume":"41","author":"MM Staron","year":"2014","unstructured":"Staron, M.M. et al. The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8+ T cells during chronic infection. Immunity 41, 802\u2013814 (2014).","journal-title":"Immunity"},{"key":"BFnm3831_CR7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"D Barber","year":"2006","unstructured":"Barber, D. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682\u2013687 (2006).","journal-title":"Nature"},{"key":"BFnm3831_CR8","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1073\/pnas.0702579104","volume":"104","author":"S Mueller","year":"2007","unstructured":"Mueller, S. et al. Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection. Proc. Natl. Acad. Sci. USA 104, 15430\u201315435 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3831_CR9","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1172\/JCI46102","volume":"121","author":"L Baitsch","year":"2011","unstructured":"Baitsch, L. et al. Exhaustion of tumor-specific CD8(+) T cells in metastases from melanoma patients. J. Clin. Invest. 121, 2350\u20132360 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFnm3831_CR10","first-page":"17","volume":"350","author":"HT Jin","year":"2011","unstructured":"Jin, H.T., Ahmed, R. & Okazaki, T. Role of PD-1 in regulating T-cell immunity. Curr. Top. Microbiol. Immunol. 350, 17\u201337 (2011).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFnm3831_CR11","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1084\/jem.20100643","volume":"207","author":"K Sakuishi","year":"2010","unstructured":"Sakuishi, K. et al. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J. Exp. Med. 207, 2187\u20132194 (2010).","journal-title":"J. Exp. Med."},{"key":"BFnm3831_CR12","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian, S.L. et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366, 2443\u20132454 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnm3831_CR13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","volume":"443","author":"CL Day","year":"2006","unstructured":"Day, C.L. et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350\u2013354 (2006).","journal-title":"Nature"},{"key":"BFnm3831_CR14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.immuni.2009.06.015","volume":"31","author":"R Tinoco","year":"2009","unstructured":"Tinoco, R., Alcalde, V., Yang, Y., Sauer, K. & Zuniga, E.I. Cell-intrinsic transforming growth factor-beta signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo. Immunity 31, 145\u2013157 (2009).","journal-title":"Immunity"},{"key":"BFnm3831_CR15","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1084\/jem.20061462","volume":"203","author":"M Ejrnaes","year":"2006","unstructured":"Ejrnaes, M. et al. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203, 2461\u20132472 (2006).","journal-title":"J. Exp. Med."},{"key":"BFnm3831_CR16","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm1492","volume":"12","author":"DG Brooks","year":"2006","unstructured":"Brooks, D.G. et al. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12, 1301\u20131309 (2006).","journal-title":"Nat. Med."},{"key":"BFnm3831_CR17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/mi.2011.7","volume":"4","author":"PS Redford","year":"2011","unstructured":"Redford, P.S., Murray, P.J. & O'Garra, A. The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol. 4, 261\u2013270 (2011).","journal-title":"Mucosal Immunol."},{"key":"BFnm3831_CR18","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.biochi.2010.02.007","volume":"92","author":"S Hara","year":"2010","unstructured":"Hara, S. et al. Prostaglandin E synthases: understanding their pathophysiological roles through mouse genetic models. Biochimie 92, 651\u2013659 (2010).","journal-title":"Biochimie"},{"key":"BFnm3831_CR19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1471-4906(01)02154-8","volume":"23","author":"SG Harris","year":"2002","unstructured":"Harris, S.G., Padilla, J., Koumas, L., Ray, D. & Phipps, R.P. Prostaglandins as modulators of immunity. Trends Immunol. 23, 144\u2013150 (2002).","journal-title":"Trends Immunol."},{"key":"BFnm3831_CR20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.1101029","volume":"188","author":"P Kalinski","year":"2012","unstructured":"Kalinski, P. Regulation of immune responses by prostaglandin e2. J. Immunol. 188, 21\u201328 (2012).","journal-title":"J. Immunol."},{"key":"BFnm3831_CR21","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.4049\/jimmunol.150.9.3747","volume":"150","author":"PA Linnemeyer","year":"1993","unstructured":"Linnemeyer, P.A. & Pollack, S.B. Prostaglandin E2-induced changes in the phenotype, morphology, and lytic activity of IL-2-activated natural killer cells. J. Immunol. 150, 3747\u20133754 (1993).","journal-title":"J. Immunol."},{"key":"BFnm3831_CR22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/icb.2011.75","volume":"90","author":"V Sreeramkumar","year":"2012","unstructured":"Sreeramkumar, V., Fresno, M. & Cuesta, N. Prostaglandin E2 and T cells: friends or foes? Immunol. Cell Biol. 90, 579\u2013586 (2012).","journal-title":"Immunol. Cell Biol."},{"key":"BFnm3831_CR23","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1084\/jem.180.6.2365","volume":"180","author":"G Strassmann","year":"1994","unstructured":"Strassmann, G., Patil-Koota, V., Finkelman, F., Fong, M. & Kambayashi, T. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 180, 2365\u20132370 (1994).","journal-title":"J. Exp. Med."},{"key":"BFnm3831_CR24","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1002\/eji.1830271254","volume":"27","author":"CE Demeure","year":"1997","unstructured":"Demeure, C.E., Yang, L.P., Desjardins, C., Raynauld, P. & Delespesse, G. Prostaglandin E2 primes naive T cells for the production of anti-inflammatory cytokines. Eur. J. Immunol. 27, 3526\u20133531 (1997).","journal-title":"Eur. J. Immunol."},{"key":"BFnm3831_CR25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich, D.I. & Nagaraj, S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162\u2013174 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnm3831_CR26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1042\/BJ20031859","volume":"384","author":"S Rahmouni","year":"2004","unstructured":"Rahmouni, S. et al. Cyclo-oxygenase type 2-dependent prostaglandin E2 secretion is involved in retrovirus-induced T-cell dysfunction in mice. Biochem. J. 384, 469\u2013476 (2004).","journal-title":"Biochem. J."},{"key":"BFnm3831_CR27","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1229620","volume":"338","author":"MA Paley","year":"2012","unstructured":"Paley, M.A. et al. Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. Science 338, 1220\u20131225 (2012).","journal-title":"Science"},{"key":"BFnm3831_CR28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ni.1679","volume":"10","author":"SD Blackburn","year":"2009","unstructured":"Blackburn, S.D. et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10, 29\u201337 (2009).","journal-title":"Nat. Immunol."},{"key":"BFnm3831_CR29","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1073\/pnas.0801497105","volume":"105","author":"SD Blackburn","year":"2008","unstructured":"Blackburn, S.D., Shin, H., Freeman, G.J. & Wherry, E.J. Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade. Proc. Natl. Acad. Sci. USA 105, 15016\u201315021 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3831_CR30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0162-3109(90)90064-L","volume":"19","author":"MM Khan","year":"1990","unstructured":"Khan, M.M., Tran, A.C. & Keaney, K.M. Forskolin and prostaglandin E2 regulate the generation of human cytolytic T lymphocytes. Immunopharmacology 19, 151\u2013161 (1990).","journal-title":"Immunopharmacology"},{"key":"BFnm3831_CR31","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1182\/blood-2011-07-365825","volume":"118","author":"N Obermajer","year":"2011","unstructured":"Obermajer, N., Muthuswamy, R., Lesnock, J., Edwards, R.P. & Kalinski, P. Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. Blood 118, 5498\u20135505 (2011).","journal-title":"Blood"},{"key":"BFnm3831_CR32","doi-asserted-by":"crossref","first-page":"6557","DOI":"10.1128\/JVI.00073-11","volume":"85","author":"FO Pettersen","year":"2011","unstructured":"Pettersen, F.O. et al. An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses. J. Virol. 85, 6557\u20136566 (2011).","journal-title":"J. Virol."},{"key":"BFnm3831_CR33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00262-010-0924-z","volume":"60","author":"Y Su","year":"2011","unstructured":"Su, Y., Jackson, E.K. & Gorelik, E. Receptor desensitization and blockade of the suppressive effects of prostaglandin E(2) and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes. Cancer Immunol. Immunother. 60, 111\u2013122 (2011).","journal-title":"Cancer Immunol. Immunother."},{"key":"BFnm3831_CR34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1476-5381.2011.01800.x","volume":"166","author":"KW Brudvik","year":"2012","unstructured":"Brudvik, K.W. & Task\u00e9n, K. Modulation of T cell immune functions by the prostaglandin E(2)\u2013cAMP pathway in chronic inflammatory states. Br. J. Pharmacol. 166, 411\u2013419 (2012).","journal-title":"Br. J. Pharmacol."},{"key":"BFnm3831_CR35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1084\/jem.193.4.497","volume":"193","author":"T Vang","year":"2001","unstructured":"Vang, T. et al. Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor. J. Exp. Med. 193, 497\u2013507 (2001).","journal-title":"J. Exp. Med."},{"key":"BFnm3831_CR36","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4049\/jimmunol.173.2.945","volume":"173","author":"JM Chemnitz","year":"2004","unstructured":"Chemnitz, J.M., Parry, R.V., Nichols, K.E., June, C.H. & Riley, J.L. SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J. Immunol. 173, 945\u2013954 (2004).","journal-title":"J. Immunol."},{"key":"BFnm3831_CR37","doi-asserted-by":"crossref","first-page":"14733","DOI":"10.1073\/pnas.1009731107","volume":"107","author":"H-T Jin","year":"2010","unstructured":"Jin, H.-T. et al. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. USA 107, 14733\u201314738 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3831_CR38","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","volume":"188","author":"AJ Zajac","year":"1998","unstructured":"Zajac, A.J. et al. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188, 2205\u20132213 (1998).","journal-title":"J. Exp. Med."},{"key":"BFnm3831_CR39","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","volume":"77","author":"EJ Wherry","year":"2003","unstructured":"Wherry, E.J., Blattman, J.N., Murali-Krishna, K., van der Most, R. & Ahmed, R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77, 4911\u20134927 (2003).","journal-title":"J. Virol."},{"key":"BFnm3831_CR40","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1126\/science.286.5445.1735","volume":"286","author":"P Bouillet","year":"1999","unstructured":"Bouillet, P. et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286, 1735\u20131738 (1999).","journal-title":"Science"},{"key":"BFnm3831_CR41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.cdd.4402034","volume":"14","author":"BA Callus","year":"2007","unstructured":"Callus, B.A. & Vaux, D.L. Caspase inhibitors: viral, cellular and chemical. Cell Death Differ. 14, 73\u201378 (2007).","journal-title":"Cell Death Differ."},{"key":"BFnm3831_CR42","doi-asserted-by":"crossref","first-page":"F109","DOI":"10.1097\/00002030-199912030-00001","volume":"13","author":"EM Aandahl","year":"1999","unstructured":"Aandahl, E.M. et al. Additive effects of IL-2 and protein kinase A type I antagonist on function of T cells from HIV-infected patients on HAART. AIDS 13, F109\u2013F114 (1999).","journal-title":"AIDS"},{"key":"BFnm3831_CR43","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1096\/fasebj.12.10.855","volume":"12","author":"EM Aandahl","year":"1998","unstructured":"Aandahl, E.M. et al. Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients. FASEB J. 12, 855\u2013862 (1998).","journal-title":"FASEB J."},{"key":"BFnm3831_CR44","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/01.aids.0000218544.54586.f1","volume":"20","author":"D Kvale","year":"2006","unstructured":"Kvale, D. et al. Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment. AIDS 20, 813\u2013820 (2006).","journal-title":"AIDS"},{"key":"BFnm3831_CR45","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/00002030-200404090-00015","volume":"18","author":"CC Johansson","year":"2004","unstructured":"Johansson, C.C. et al. Treatment with type-2 selective and non-selective cyclooxygenase inhibitors improves T-cell proliferation in HIV-infected patients on highly active antiretroviral therapy. AIDS 18, 951\u2013952 (2004).","journal-title":"AIDS"},{"key":"BFnm3831_CR46","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","volume":"13","author":"AM Algra","year":"2012","unstructured":"Algra, A.M. & Rothwell, P.M. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol. 13, 518\u2013527 (2012).","journal-title":"Lancet Oncol."},{"key":"BFnm3831_CR47","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","volume":"348","author":"JA Baron","year":"2003","unstructured":"Baron, J.A. et al. A randomized trial of aspirin to prevent colorectal adenomas. N. Engl. J. Med. 348, 891\u2013899 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnm3831_CR48","doi-asserted-by":"crossref","first-page":"8627","DOI":"10.1128\/JVI.00855-06","volume":"80","author":"JM Grayson","year":"2006","unstructured":"Grayson, J.M., Weant, A.E., Holbrook, B.C. & Hildeman, D. Role of Bim in regulating CD8+ T-cell responses during chronic viral infection. J. Virol. 80, 8627\u20138638 (2006).","journal-title":"J. Virol."},{"key":"BFnm3831_CR49","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1172\/JCI33402","volume":"118","author":"AR Lopes","year":"2008","unstructured":"Lopes, A.R. et al. Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection. J. Clin. Invest. 118, 1835\u20131845 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnm3831_CR50","doi-asserted-by":"crossref","first-page":"20858","DOI":"10.1074\/jbc.M310643200","volume":"279","author":"L Zhang","year":"2004","unstructured":"Zhang, L. & Insel, P.A. The pro-apoptotic protein Bim is a convergence point for cAMP\/protein kinase A- and glucocorticoid-promoted apoptosis of lymphoid cells. J. Biol. Chem. 279, 20858\u201320865 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnm3831_CR51","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1074\/jbc.M708673200","volume":"283","author":"L Zhang","year":"2008","unstructured":"Zhang, L. et al. Gene expression signatures of cAMP\/protein kinase A (PKA)-promoted, mitochondrial-dependent apoptosis. Comparative analysis of wild-type and cAMP-deathless S49 lymphoma cells. J. Biol. Chem. 283, 4304\u20134313 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFnm3831_CR52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/embor.2010.190","volume":"12","author":"D Moujalled","year":"2011","unstructured":"Moujalled, D. et al. Cyclic-AMP-dependent protein kinase A regulates apoptosis by stabilizing the BH3-only protein Bim. EMBO Rep. 12, 77\u201383 (2011).","journal-title":"EMBO Rep."},{"key":"BFnm3831_CR53","doi-asserted-by":"crossref","first-page":"33260","DOI":"10.1074\/jbc.M111.268979","volume":"286","author":"AC Zambon","year":"2011","unstructured":"Zambon, A.C., Wilderman, A., Ho, A. & Insel, P.A. Increased expression of the pro-apoptotic protein BIM, a mechanism for cAMP\/protein kinase A (PKA)-induced apoptosis of immature T cells. J. Biol. Chem. 286, 33260\u201333267 (2011).","journal-title":"J. Biol. Chem."},{"key":"BFnm3831_CR54","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1172\/JCI67008","volume":"123","author":"EE West","year":"2013","unstructured":"West, E.E. et al. PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells. J. Clin. Invest. 123, 2604\u20132615 (2013).","journal-title":"J. Clin. Invest."},{"key":"BFnm3831_CR55","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/eji.200637023","volume":"37","author":"MF Bachmann","year":"2007","unstructured":"Bachmann, M.F., Wolint, P., Walton, S., Schwarz, K. & Oxenius, A. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections. Eur. J. Immunol. 37, 1502\u20131512 (2007).","journal-title":"Eur. J. Immunol."},{"key":"BFnm3831_CR56","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nm866","volume":"9","author":"JN Blattman","year":"2003","unstructured":"Blattman, J.N. et al. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat. Med. 9, 540\u2013547 (2003).","journal-title":"Nat. Med."},{"key":"BFnm3831_CR57","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/5583","volume":"5","author":"CR Kennedy","year":"1999","unstructured":"Kennedy, C.R. et al. Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat. Med. 5, 217\u2013220 (1999).","journal-title":"Nat. Med."},{"key":"BFnm3831_CR58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/gene.20048","volume":"40","author":"A Schneider","year":"2004","unstructured":"Schneider, A. et al. Generation of a conditional allele of the mouse prostaglandin EP4 receptor. Genesis 40, 7\u201314 (2004).","journal-title":"Genesis"},{"key":"BFnm3831_CR59","doi-asserted-by":"crossref","first-page":"9044","DOI":"10.1073\/pnas.1332766100","volume":"100","author":"CE Trebino","year":"2003","unstructured":"Trebino, C.E. et al. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc. Natl. Acad. Sci. USA 100, 9044\u20139049 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3831_CR60","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/21208","volume":"399","author":"J Jacob","year":"1999","unstructured":"Jacob, J. & Baltimore, D. Modelling T-cell memory by genetic marking of memory T cells in vivo. Nature 399, 593\u2013597 (1999).","journal-title":"Nature"},{"key":"BFnm3831_CR61","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.immuni.2007.07.010","volume":"27","author":"NS Joshi","year":"2007","unstructured":"Joshi, N.S. et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27, 281\u2013295 (2007).","journal-title":"Immunity"},{"key":"BFnm3831_CR62","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.160.2.521","volume":"160","author":"R Ahmed","year":"1984","unstructured":"Ahmed, R., Salmi, A., Butler, L.D., Chiller, J.M. & Oldstone, M.B. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160, 521\u2013540 (1984).","journal-title":"J. Exp. Med."},{"key":"BFnm3831_CR63","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.4049\/jimmunol.172.7.4204","volume":"172","author":"MJ Fuller","year":"2004","unstructured":"Fuller, M.J., Khanolkar, A., Tebo, A.E. & Zajac, A.J. Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections. J. Immunol. 172, 4204\u20134214 (2004).","journal-title":"J. Immunol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.3831.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3831","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3831.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T23:17:16Z","timestamp":1691536636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.3831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,23]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["BFnm3831"],"URL":"https:\/\/doi.org\/10.1038\/nm.3831","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,23]]},"assertion":[{"value":"23 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.H.C. and S.M.K. have applied for a patent based in part on the findings outlined in this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}